Top Performing Funds

Top performers Growth
1 Morgan Stanley Global Value Equity TR in GB 21.02%
2 FF&P US Small Cap Equity TR in GB 14.59%
3 JPM US Smaller Companies TR in GB 13.44%
4 Melchior North America Opportunities TR in GB 12.95%
5 Schroder US Smaller Companies TR in GB 12.77%
View more performance data


NewsRSS

Should you buy Anthony Bolton's new fund?

Is it a lifetime opportunity? Or are there too many bulls in the China shop? China tends to generate extreme comments, either full of dire warnings or uncompromisingly bullish (oblivious to the risks). Here we try and provide a more balanced view - so we will probably upset both the optimists and the pessimists! In summary, engage brain before you rush for your cheque book. More >


Added: 02.03.2010

View all news articles >

More News

House price balance records surprise fall 09.03.2010 More >


MPs criticise poor performance at the Revenue 09.03.2010 More >


Most Popular Links

BlogsRSS

UK outperforming India and China? Surely a mistake?

Over the last month the UK stock market has performed somewhat better than those of even the high growth areas of India and China. Why? Is it anomalous? Currency has been the big driver for UK-based investors, whether you have been invested in the UK stock market or in overseas markets. Here we explore what has happened, and also touch on Asia and emerging markets and corporate bonds. More >


Updated: 09.03.2010

View all posts >


 

Register for alerts

Enter your email address below and we’ll automatically email you when we publish new alerts or research


This information solely used to send you our e-alerts



... read more

 




Dennehy Weller & Co Ltd, 3 High Street, Chislehurst, Kent, BR7 5AB. Tel: 020 8467 1666. Authorised and regulated by the Financial Services Authority (http://www.fsa.gov.uk/register/home.do). FSA Registration No: 114360. Registered in England & Wales, No. 1476316. Registered Office: 303 High Street, Orpington, Kent, BR6 0NN. The information contained within this site is subject to the UK regulatory regime and is therefore targeted primarily at investors based in the UK.